Pharmaceutical giant AstraZeneca is pledging $820 million towards an expanded research and development hub in Mississauga, the company says.
The investment will bankroll the firm’s move to a larger office facility in Mississauga and generate more than 700 jobs across all divisions of the company, AstraZeneca said in a Jan. 23 press release.
